7.360CAD-0.67%Mkt Cap: 2.75B CADP/E: —Last update: 2026-06-01
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The comp…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap2.75B CAD
Enterprise Value23.24B CAD
Revenue (TTM)10.53B CAD
Gross Profit7.25B CAD
Net Income (TTM)157.00M CAD
Revenue/Share28.33 CAD
Last Price7.360 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees20.3K
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA0717341071
Valuation
P/E (Trailing)—
P/E (Forward)1.32
PEG0.02
EV/EBITDA6.43
EV/Revenue2.21
P/S0.26
P/B-0.98
EPS (TTM)-4.49
EPS (Forward)5.62
52W Range
6.06022% of range11.97
52W High11.97 CAD
52W Low6.060 CAD
Profitability
Gross Margin70.65%
Oper. Margin20.64%
EBITDA Margin34.32%
Profit Margin1.53%
ROE-28.34%
ROA0.60%
Growth
Revenue Growth11.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF1.40B CAD
CapEx (TTM)407.00M CAD
FCF Margin10.67%
FCF Yield40.87%
Net Debt19.50B CAD
Net Debt/EBITDA5.39
Balance Sheet
Debt/Equity-37.64
Current Ratio1.32
Quick Ratio0.77
Book Value/Sh-7.5991 CAD
Cash/Share3.478 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield6.46%
Payout Ratio0.00%
Ex-Div DateNov 10, 2010
Pay Date—
Splits
Last Split2:1
Split DateOct 5, 2000
Analyst Consensus
Rating2.9 (Hold)
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.373.48M
Float260.41M
Insiders10.82%
Institutions65.11%
Short Interest
Short Ratio7.7d
Short % Float1.04%
Short % Out.0.83%
Shares Short3.09M
Short (prev mo.)3.13M
Technical
SMA 507.524 (-2.2%)
SMA 2008.696 (-15.4%)
Beta0.42
S&P 52W Chg27.70%
Avg Vol (30d)438.65K
Avg Vol (10d)426.03K
Technical Indicators
RSI (14)45.7
MACD-0.0428
MACD Signal-0.0353
MACD Hist.-0.0075
BB Upper7.877 CAD
BB Middle7.535 CAD
BB Lower7.192 CAD
BB Width9.10%
ATR (14)0.2821 CAD
Vol Ratio (20d)1.98x